| 1 |
24528208 | Milestones in understanding platelet production: a historical overview. | 2014 Apr |
2 |
| 2 |
21832269 | Nonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects. | 2011 Aug |
4 |
| 3 |
18211568 | New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. | 2008 Feb |
1 |
| 4 |
18728031 | The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. | 2008 Oct |
3 |
| 5 |
16043461 | Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia. | 2005 Aug |
1 |
| 6 |
14530872 | Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study. | 2003 Nov |
1 |
| 7 |
11976502 | Crystallization of the functional domain of human thrombopoietin using an antigen-binding fragment derived from neutralizing monoclonal antibody. | 2002 May |
1 |
| 8 |
10757421 | Effects of pegylated recombinant human megakaryocyte growth and development factor on 5-fluorouracil-induced thrombocytopenia in balloon-injured rats. | 2000 Mar |
1 |
| 9 |
11146158 | Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro. | 2000 Dec |
1 |
| 10 |
9446643 | Effects of cytokines on platelet production from blood and marrow CD34+ cells. | 1998 Feb 1 |
1 |
| 11 |
9450813 | Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). | 1998 Jan |
1 |
| 12 |
9472777 | Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. | 1998 Jan 20 |
4 |
| 13 |
9658720 | Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line. | 1998 May |
1 |
| 14 |
9664160 | Update on thrombopoietin in preclinical and clinical trials. | 1998 May |
1 |
| 15 |
10227790 | Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice. | 1998 Feb |
1 |
| 16 |
9010146 | Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. | 1997 Feb 6 |
7 |
| 17 |
9359514 | The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia. | 1997 Oct |
1 |
| 18 |
8695799 | Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. | 1996 Jul 15 |
2 |
| 19 |
8704197 | Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. | 1996 Jul 1 |
2 |
| 20 |
8909381 | Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. | 1996 Nov 9 |
1 |